Literature DB >> 25059099

Updated NICE guideline: management of atrial fibrillation (2014).

Keitaro Senoo1, Yee Cheng Lau, Gregory Yh Lip.   

Abstract

There is significant progress made in the field of atrial fibrillation, especially regarding stroke stratification, novel pharmacological agents and interventions for improving symptom control. The Updated NICE Guideline for management of 2014 reflects that and provided an up-to-date appraisal regarding atrial fibrillation treatment, management with consideration to overall healthcare cost economics. It emphasizes the need for individualized, patient-centered package of care, and an robust stroke and bleeding risk before decision regarding choice of oral anticoagulation to be made.

Entities:  

Keywords:  atrial fibrillation; guideline; ischaemic stroke prevention; risk stratification; symptom management

Mesh：

Substances：

Year:  2014        PMID： 25059099     DOI： 10.1586/14779072.2014.943189

Source DB:  PubMed          Journal:  Expert Rev Cardiovasc Ther        ISSN： 1477-9072


  10 in total

1.  TIMI-AF score and cardiovascular events in vitamin K antagonists-naïve outpatients with atrial fibrillation.

Authors:  Alejandro Isidoro Pérez Cabeza; Rafael Bravo Marques; Pedro Antonio Chinchurreta Capote; Francisco Ruiz Mateas; Christina L Fanola; Gabriel Rosas Cervantes; Jose Antonio González Correa; Almudena Valle Alberca; Fidel Mesa Prado; Sergio López Tejero; Christian Thomas Ruff
Journal:  Clin Cardiol       Date:  2018-08-20       Impact factor: 2.882

2.  Risk of myocardial infarction in patients with atrial fibrillation using vitamin K antagonists, aspirin or direct acting oral anticoagulants.

Authors:  Leo M Stolk; Frank de Vries; Chiel Ebbelaar; Anthonius de Boer; Tom Schalekamp; Patrick Souverein; Arina Ten Cate-Hoek; Andrea M Burden
Journal:  Br J Clin Pharmacol       Date:  2017-03-23       Impact factor: 4.335

3.  Stroke Prophylaxis for Atrial Fibrillation? To Prescribe or Not to Prescribe-A Qualitative Study on the Decisionmaking Process of Emergency Department Providers.

Authors:  Bory Kea; Tahroma Alligood; Cassandra Robinson; Josephine Livingston; Benjamin C Sun
Journal:  Ann Emerg Med       Date:  2019-05-09       Impact factor: 5.721

4.  Prognostic value of interleukin-6 in atrial fibrillation: A cohort study and meta-analysis.

Authors:  Xiaoyue Jia; Xi Cheng; Na Wu; Ying Xiang; Long Wu; Bin Xu; Chengying Li; Zhihui Zhang; Shifei Tong; Li Zhong; Yafei Li
Journal:  Anatol J Cardiol       Date:  2021-12       Impact factor: 1.596

Review 5.  Thrombophilia testing in the era of direct oral anticoagulants.

Authors:  Jennifer Darlow; Holly Mould
Journal:  Clin Med (Lond)       Date:  2021-09-07       Impact factor: 5.410

Review 6.  Decision-Making in Clinical Practice: Oral Anticoagulant Therapy in Patients with Non-valvular Atrial Fibrillation and a Single Additional Stroke Risk Factor.

Authors:  Tatjana S Potpara; Nikolaos Dagres; Nebojša Mujović; Dragan Vasić; Milika Ašanin; Milan Nedeljkovic; Francisco Marin; Laurent Fauchier; Carina Blomstrom-Lundqvist; Gregory Y H Lip
Journal:  Adv Ther       Date:  2016-12-08       Impact factor: 3.845

7.  Evaluating outcomes of same-day discharge after catheter ablation for atrial fibrillation in a real-world cohort.

Authors:  Michael E Field; Laura Goldstein; Kevin Corriveau; Rahul Khanna; Xiaozhou Fan; Michael R Gold
Journal:  Heart Rhythm O2       Date:  2021-07-14

8.  Differences in outcomes among patients with atrial fibrillation undergoing catheter ablation with versus without intracardiac echocardiography.

Authors:  Rhea C Pimentel; Neloufar Rahai; Sonia Maccioni; Rahul Khanna
Journal:  J Cardiovasc Electrophysiol       Date:  2022-07-23       Impact factor: 2.942

9.  Catheter Ablation versus Thoracoscopic Surgical Ablation in Long Standing Persistent Atrial Fibrillation (CASA-AF): study protocol for a randomised controlled trial.

Authors:  Habib Rehman Khan; Ines Kralj-Hans; Shouvik Haldar; Toufan Bahrami; Jonathan Clague; Anthony De Souza; Darrel Francis; Wajid Hussain; Julian Jarman; David Gareth Jones; Neeraj Mediratta; Raad Mohiaddin; Tushar Salukhe; Simon Jones; Joanne Lord; Caroline Murphy; Joanna Kelly; Vias Markides; Dhiraj Gupta; Tom Wong
Journal:  Trials       Date:  2018-02-20       Impact factor: 2.279

10.  Switching warfarin to direct oral anticoagulants in atrial fibrillation: Insights from the NCDR PINNACLE registry.

Authors:  Christopher T Sciria; Thomas M Maddox; Lucas Marzec; Benjamin Rodwin; Salim S Virani; Amarnath Annapureddy; James V Freeman; Ali O'Hare; Yuyin Liu; Yang Song; Gheorghe Doros; Yue Zheng; Jane J Lee; Ramesh Daggubati; Lina Vadlamani; Christopher Cannon; Nihar R Desai
Journal:  Clin Cardiol       Date:  2020-05-06       Impact factor: 3.287
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.